Literature DB >> 19205719

A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.

Yazmin Yactayo-Miranda1, Christopher N Ta, Lisa He, Thomas C Kreutzer, Martin M Nentwich, Anselm Kampik, Herminia Mino de Kaspar.   

Abstract

BACKGROUND: To determine the efficacy of conjunctival bacterial eradication following a 1-day, 3-day and 7-day application of topical 0.5% levofloxacin, with and without eyelid scrub, in patients with chronic blepharoconjunctivitis (CBC).
METHODS: Patients with CBC (n = 60) were prospectively randomized to three groups (n = 20 in each group): no antibiotic treatment, topical levofloxacin four times per day in both eyes, and eyelid scrub in addition to topical levovofloxacin four times a day in both eyes. Patients without CBC (n = 40) were enrolled as the negative control group. Cultures of the conjunctiva were obtained from both eyes at baseline, 1 day, 3 days, and 7 days following treatment.
RESULTS: The most common bacteria isolated for all groups at baseline were coagulase-negative Staphylococcus. Eight patients did not complete the study. The remaining 52 patients with CBC had a significantly higher rate of positive thioglycolate broth cultures (94%) compared to a 58% positive culture rate in patient without CBC (P < 0.0001). Treatment with at least 3 days of topical antibiotic in patient with CBC resulted in a significant reduction (P < 0.05) in the number of thioglycolate positive cultures (<or= 60%) compared to non-treated eyes (>or= 88%). Following a minimum of a 1-day application of antibiotic, the median colony-forming unit was 0-1 compared to 3-8 for eyes without antibiotic treatment (P < 0.05). Scrubbing of the eyelids did not provide further benefit compared to antibiotic treatment alone.
CONCLUSIONS: CBC eyes have a significantly higher number of positive cultures than eyes without CBC. The application of topical 0.5% levofloxacin for at least 3 days provided a significant reduction in the number of positive cultures as well as the number of bacteria harbored on the conjunctival surface.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205719     DOI: 10.1007/s00417-009-1039-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Lid flora in blepharitis.

Authors:  L R Groden; B Murphy; J Rodnite; G I Genvert
Journal:  Cornea       Date:  1991-01       Impact factor: 2.651

2.  Chronic blepharitis: easy nursing interventions for a common problem.

Authors:  B Faherty
Journal:  J Ophthalmic Nurs Technol       Date:  1992 Jan-Feb

Review 3.  Blepharitis.

Authors:  E M Raskin; M G Speaker; P R Laibson
Journal:  Infect Dis Clin North Am       Date:  1992-12       Impact factor: 5.982

4.  Bacterial lipases and chronic blepharitis.

Authors:  J M Dougherty; J P McCulley
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-04       Impact factor: 4.799

5.  Minocycline effect on meibomian gland lipids in meibomianitis patients.

Authors:  W E Shine; J P McCulley; A G Pandya
Journal:  Exp Eye Res       Date:  2003-04       Impact factor: 3.467

6.  Treatment of blepharitis and blepharoconjunctivitis: comparison of gentamicin-betamethasone, gentamicin alone and placebo.

Authors:  W B Jackson; W M Easterbrook; W E Connolly; W D Leers
Journal:  Can J Ophthalmol       Date:  1982-08       Impact factor: 1.882

7.  Classification of chronic blepharitis.

Authors:  J P McCulley; J M Dougherty; D G Deneau
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

8.  Blepharitis--a diagnostic and therapeutic challenge. A report on 407 consecutive cases.

Authors:  V Huber-Spitzy; I Baumgartner; K Böhler-Sommeregger; G Grabner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

9.  Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.

Authors:  D G Shulman; J B Sargent; R H Stewart; U Mester
Journal:  Eur J Ophthalmol       Date:  1996 Oct-Dec       Impact factor: 1.922

10.  Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.

Authors:  P A Bloom; J P Leeming; W Power; D A Laidlaw; L M Collum; D L Easty
Journal:  Eur J Ophthalmol       Date:  1994 Jan-Mar       Impact factor: 1.922

View more
  4 in total

Review 1.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 3.  Topical Steroids and Antibiotics for Adult Blepharokeratoconjunctivitis (BKC): A Meta-Analysis of Randomized Clinical Trials.

Authors:  Lu Zhao; Ya-Jie Sun; Zhi-Qiang Pan
Journal:  J Ophthalmol       Date:  2021-01-08       Impact factor: 1.909

4.  Research Trends and Hotspot Analysis of Conjunctival Bacteria Based on CiteSpace Software.

Authors:  Zhenyu Wang; Chen Huang; Xuemin Li
Journal:  Biomed Res Int       Date:  2020-10-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.